Renaissance Technologies’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.2K | Buy |
+8,720
| New | +$46.2K | ﹤0.01% | 3405 |
|
|
2025
Q1 | – | Sell |
-23,330
| Closed | -$163K | – | 3874 |
|
|
2024
Q4 | $163K | Buy |
23,330
+8,534
| +58% | +$59.7K | ﹤0.01% | 3215 |
|
|
2024
Q3 | $215K | Buy |
14,796
+10,243
| +225% | +$149K | ﹤0.01% | 3105 |
|
|
2024
Q2 | $332K | Buy |
+4,553
| New | +$332K | ﹤0.01% | 2869 |
|
|
2023
Q4 | – | Sell |
-6,810
| Closed | -$265K | – | 4174 |
|
|
2023
Q3 | $265K | Sell |
6,810
-9,120
| -57% | -$355K | ﹤0.01% | 2990 |
|
|
2023
Q2 | $919K | Buy |
15,930
+10,280
| +182% | +$593K | ﹤0.01% | 2517 |
|
|
2023
Q1 | $367K | Sell |
5,650
-9,987
| -64% | -$649K | ﹤0.01% | 3027 |
|
|
2022
Q4 | $430K | Sell |
15,637
-7,393
| -32% | -$203K | ﹤0.01% | 3034 |
|
|
2022
Q3 | $672K | Buy |
23,030
+18,240
| +381% | +$532K | ﹤0.01% | 2734 |
|
|
2022
Q2 | $92K | Buy |
+4,790
| New | +$92K | ﹤0.01% | 3873 |
|
|
2020
Q1 | – | Sell |
-1,390
| Closed | -$221K | – | 3838 |
|
|
2019
Q4 | $221K | Buy |
+1,390
| New | +$221K | ﹤0.01% | 3168 |
|